SENZIME
Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting. The solutions... are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of SEK 10 billion. The company's shares are listed on Nasdaq First North (ticker SEZI). FNCA is Certified Adviser for Senzime.
SENZIME
Industry:
Health Diagnostics Medical Device
Founded:
1999-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.senzime.com
Total Employee:
1+
Status:
Active
Contact:
+46 (0)18-51 56 40
Email Addresses:
[email protected]
Total Funding:
363.97 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Domain Not Resolving Nginx Sitelinks Search Box Euro
Similar Organizations
UE LifeSciences
UE LifeSciences is a female technology company building preventive oncology solutions for primary care and home.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-05-03 | Acacia Designs | Acacia Designs acquired by Senzime | N/A |
| 2015-04-24 | MD Biomedical | MD Biomedical acquired by Senzime | N/A |
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Senzime
Official Site Inspections
http://www.senzime.com
- Host name: ec2-52-17-142-199.eu-west-1.compute.amazonaws.com
- IP address: 52.17.142.199
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Senzime"
About - Senzime
Senzime is a leading global medical device company, developing precision-based patient monitoring solutions that drive a global paradigm shift in perioperative patient safety. With our …See details»
Senzime | Precision-based patient monitoring
6 days ago Senzime comments on US market tariffs. Apr 01, 2025 • 08:40. New number of shares and votes in Senzime AB (publ) News and press releases. Latest reports Feb 17, …See details»
Management - Senzime
Own and related parties’ shareholding in Senzime: 1,561 shares. 40,000 stock options in program 2022/2026, 75, 000 stock options in program 2023/2027, ... Founding Board Member and …See details»
Senzime - Crunchbase Company Profile & Funding
Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, …See details»
Senzime AB (publ) (SNZZF) Company Profile & Overview
Mar 7, 2025 Senzime AB Company Description Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to …See details»
Senzime - Org Chart, Teams, Culture & Jobs | The Org
View Senzime's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Senzime Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Senzime has 5 employees across 2 locations and kr35.75 m in annual revenue in FY 2023. See insights on Senzime including office locations, competitors, revenue, financials, …See details»
Senzime - Org chart | The Org
Explore Senzime's organizational chart. Discover current team members including executives, board members, and advisors.See details»
About Senzime - PharmiWeb.jobs
Dec 21, 2023 Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems.Senzime’s employees worldwide …See details»
Senzime - Company Profile - Tracxn
Feb 26, 2025 Senzime - Analytical instruments for continuous monitoring. Public Company. Raised a total funding of $8.25M over 7 rounds from 5 investors.See details»
Senzime - Overview, News & Similar companies | ZoomInfo.com
Apr 25, 2023 Senzime AB (publ) today announces that the company’s Annual report for year 2020 is now available in Swedish on the company’s website www.senzime.com For further …See details»
Investors - Senzime
Feb 17, 2025 Senzime is listed on Nasdaq Main Market (SEZI) and cross traded in the US on the OTCQX list (SNZZF). Investment case Senzime’s goal is to become market leader in …See details»
NOTICE OF ANNUAL GENERAL MEETING in Senzime AB (publ)
2 days ago UPPSALA, SE / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565 …See details»
Invitation to Presentation of Senzime's First Quarter 2025 Report
2 days ago UPPSALA, SWEDEN / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation …See details»
Senzime AB (publ), SNZZF:QXE profile - FT.com - Financial Times
Feb 20, 2025 Senzime AB (publ) (SNZZF:QXE) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Senzime AB Company Profile & Data: stocks, market cap, financials ...
Jan 1, 2025 Senzime AB (publ) was incorporated in 1999 and is based in Uppsala, Sweden. Top 1-year algo backtest: +327.04% $10,000 in March 2024 would now be $42,704 by following …See details»
Our strategy & business model - Senzime
Senzime has also entered into several strategic licensing agreements in product development and sales. Our business cornerstones The five cornerstones of our business model to execute our …See details»
Senzime, a Potential 10-Bagger? - Quality Stocks
Nov 9, 2024 Senzime's advanced technology is safeguarded by over 100 patents, with a commitment to consistently expanding its patent portfolio. In 2023 and 2022, R&D …See details»
Senzime (OM:SEZI) - Stock Price, News & Analysis - Simply Wall St
3 days ago Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and …See details»
Senzime: Back on track – Q1 preview | MarketScreener
7 hours ago Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such …See details»